Page results
-
Health and wellbeing information for people affected by cancer.
-
Health and wellbeing information for people affected by cancer.
-
The primary objective of the ENT urgent referral clinic is to provide speedy access and effective care to all adult and paediatric patients aged above two years old with urgent ENT problems.
-
This information has been developed by the welfare and benefits team based in the Macmillan Support and Information Service. It outlines the most common benefits available.
-
The Royal London Hospital for Integrated Medicine (RLHIM) is a centre for evidence-based practice, education and research, specialising in chronic and complex medical conditions.
-
Our education department at the Royal London Hospital for Integrated Medicine, runs courses in integrated medicine for statutory registered health professionals.
-
The Integrated Children’s and Adolescent Service has been established to provide complementary care alongside orthodox treatments. The clinic sees children up to 18 years old with a wide variety of illnesses.
-
Information about the integrated general medicine service at the Royal London Hospital for Integrated Medicine.
-
Information about the integrated occupational therapy service at the Royal London Hospital for Integrated Medicine
-
The Ataxia Centre brings together a team of specialists, with expertise in the diagnosis, management and research of all forms of ataxia.
File results
-
FOI/2024/0511 - Radiotherapy treatment planning system/artificial intelligence (AI)/ costs
-
FOI/2024/0512 - Patient harm and the cost 2020-2023
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0520 - Treatment of melanoma